Mark For: BYFAVO® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88099395 |
Registration Number | 6380712 |
Mark Literal Elements | BYFAVO |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2021-05-03 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | Yes |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | John Pickerill |
Attorney Docket Number | 76724.28 |
Law Office Assigned | M10 |
Employee Name | NADELMAN, ANDREA KOYNE |
2018-08-30 | Application Filed |
2019-08-06 | Published |
2019-08-06 | Published for Opposition |
2019-10-01 | Location: INTENT TO USE SECTION |
2019-10-01 | Status: Live/Pending |
2019-10-01 | Transaction Date |
2021-01-01 | Date of First Use |
2021-01-01 | Date of Use In Commerce |
2021-05-03 | Location: PUBLICATION AND ISSUE SECTION |
2021-06-08 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2021-06-08 | Trademark Registered |
Party: | ACACIA PHARMA LIMITED |
Address | THE OFFICER'S MESS, ROYSTON ROAD, DUXFORD CAMBRIDGE UNITED KINGDOM CB224QH |
Legal Entity Type | Private Limited Company |
Legal Entity State | ENGLAND AND WALES |
Party: | Cosmo Technologies Ltd |
Entity Statement | limited company (ltd.) |
Address | Riverside II Sir John Rogerson's Quay Dublin 2 IE 0 |
Legal Entity Type | |
Legal Entity State | IE |
IC 005. US 005 006 018 044 046 051 052. G & S: pharmaceutical preparations for use in sedation, general sedation, procedural sedation, intensive care medicine sedation, moderate sedation and conscious sedation; sedatives; pharmaceutical preparations to facilitate sedation or anesthesia for dental surgery; pharmaceutical preparations to facilitate sedation for colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative preparations for use in the field of sedation or anesthesia in intensive care medicine; pharmaceutical preparations for use for sedation and anesthesia in the fields of cardiology, radiology, vascular surgery, emergency medicine, outpatient surgeries, dermatology, plastic surgery and orthopaedics; pharmaceutical preparations for use for sedation and anesthesia in the diagnosis or treatment of skin and soft tissue injuries or disorders; pharmaceutical preparations for use for sedation and anesthesia in surgical procedures of the skin and soft tissue; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during therapeutic and diagnostic procedures; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during surgery; pharmaceutical sedative and anesthetic preparations for use in colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative and anesthetic preparations for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical sedative and anesthetic preparations for use in surgical procedures; pharmaceutical sedative and anesthetic preparations for use in the following procedures: cardiac catherization, interventional radiology, endovascular procedures, peripheral angioplasty, cardiac defibrillator, implantation of peripheral stents and pacemakers, adjustment of peripheral stents and pacemakers, removal of peripheral stents and pacemakers, dermatologic procedures and oral surgery. FIRST USE: 20210100. FIRST USE IN COMMERCE: 20210100
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for use in sedation, general sedation, procedural sedation, intensive care medicine sedation, moderate sedation and conscious sedation; pharmaceutical preparations for use as a general anesthetic; pharmaceutical anesthetic preparations for use in the field of anesthesia; anesthetics; anesthetic preparations; sedatives; pharmaceutical preparations to facilitate sedation or anesthesia for dental surgery; pharmaceutical preparations to facilitate sedation for colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative preparations for use in the field of sedation or anesthesia in intensive care medicine; pharmaceutical preparations for use for sedation and anesthesia in the fields of cardiology, radiology, vascular surgery, emergency medicine, outpatient surgeries, dermatology, plastic surgery and orthopaedics; pharmaceutical preparations for use for sedation and anesthesia in the diagnosis or treatment of skin and soft tissue injuries or disorders; pharmaceutical preparations for use for sedation and anesthesia in surgical procedures of the skin and soft tissue; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during therapeutic and diagnostic procedures; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during surgery; pharmaceutical sedative and anesthetic preparations for use in colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative and anesthetic preparations for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical sedative and anesthetic preparations for use in surgical procedures; pharmaceutical sedative and anesthetic preparations for use in the following procedures: cardiac catherization, interventional radiology, endovascular procedures, peripheral angioplasty, cardiac defibrillator, implantation of peripheral stents and pacemakers, adjustment of peripheral stents and pacemakers, removal of peripheral stents and pacemakers, dermatologic procedures and oral surgery |
GS0051 | pharmaceutical preparations for use in sedation, general sedation, procedural sedation, intensive care medicine sedation, moderate sedation and conscious sedation; sedatives; pharmaceutical preparations to facilitate sedation or anesthesia for dental surgery; pharmaceutical preparations to facilitate sedation for colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative preparations for use in the field of sedation or anesthesia in intensive care medicine; pharmaceutical preparations for use for sedation and anesthesia in the fields of cardiology, radiology, vascular surgery, emergency medicine, outpatient surgeries, dermatology, plastic surgery and orthopaedics; pharmaceutical preparations for use for sedation and anesthesia in the diagnosis or treatment of skin and soft tissue injuries or disorders; pharmaceutical preparations for use for sedation and anesthesia in surgical procedures of the skin and soft tissue; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during therapeutic and diagnostic procedures; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during surgery; pharmaceutical sedative and anesthetic preparations for use in colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative and anesthetic preparations for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical sedative and anesthetic preparations for use in surgical procedures; pharmaceutical sedative and anesthetic preparations for use in the following procedures: cardiac catherization, interventional radiology, endovascular procedures, peripheral angioplasty, cardiac defibrillator, implantation of peripheral stents and pacemakers, adjustment of peripheral stents and pacemakers, removal of peripheral stents and pacemakers, dermatologic procedures and oral surgery |
Description | Date | Proceeding Number |
---|---|---|
REGISTERED-PRINCIPAL REGISTER | 2021-06-08 | |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2021-06-01 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-06-01 | |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-06-01 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-06-01 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-06-01 | |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-05-04 | |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-05-03 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-04-20 | |
STATEMENT OF USE PROCESSING COMPLETE | 2021-04-19 | 66154 |
EXTENSION 3 GRANTED | 2021-04-19 | 66154 |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-03-15 | 66154 |
USE AMENDMENT FILED | 2021-02-25 | 66154 |
TEAS STATEMENT OF USE RECEIVED | 2021-02-25 | |
TEAS EXTENSION RECEIVED | 2021-02-25 | |
EXTENSION 3 FILED | 2021-02-25 | 66154 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-02-22 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-02-22 | |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-02-22 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-02-22 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-02-22 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-02-22 | 88888 |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2021-02-17 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-09-04 | |
TEAS EXTENSION RECEIVED | 2020-09-02 | |
EXTENSION 2 GRANTED | 2020-09-02 | 98765 |
EXTENSION 2 FILED | 2020-09-02 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-03-21 | |
TEAS EXTENSION RECEIVED | 2020-03-19 | |
EXTENSION 1 GRANTED | 2020-03-19 | 98765 |
EXTENSION 1 FILED | 2020-03-19 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-10-01 | |
PUBLISHED FOR OPPOSITION | 2019-08-06 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-08-06 | |
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2019-08-06 | 67832 |
ASSIGNED TO PETITION STAFF | 2019-07-29 | 67832 |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-07-17 | |
TEAS POST PUBLICATION AMENDMENT RECEIVED | 2019-07-08 | 1111 |
ASSIGNED TO LIE | 2019-07-01 | 70138 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-20 | 88889 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-06-20 | |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2019-06-19 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-06-19 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-06-19 | 88889 |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-05-28 | |
FINAL REFUSAL WRITTEN | 2019-05-28 | 76507 |
FINAL REFUSAL E-MAILED | 2019-05-28 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-05-25 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-05-24 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-24 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-11-28 | |
NON-FINAL ACTION WRITTEN | 2018-11-28 | 76507 |
NON-FINAL ACTION E-MAILED | 2018-11-28 | |
ASSIGNED TO EXAMINER | 2018-11-21 | 76507 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-10 | |
NEW APPLICATION ENTERED IN TRAM | 2018-09-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.